[HTML][HTML] The future: genetics advances in MEN1 therapeutic approaches and management strategies

SK Agarwal - Endocrine-related cancer, 2017 - ncbi.nlm.nih.gov
The identification of the multiple endocrine neoplasia type 1 (MEN1) gene in 1997 has
shown that germline heterozygous mutations in the MEN1 gene located on chromosome …

[HTML][HTML] Phenotypes associated with MEN1 syndrome: a focus on genotype-phenotype correlations

C Mele, M Mencarelli, M Caputo, S Mai… - Frontiers in …, 2020 - frontiersin.org
Multiple endocrine neoplasia type 1 (MEN1) is a rare autosomal dominant inherited tumor
syndrome, associated with parathyroid, pituitary, and gastro-entero-pancreatic (GEP) …

[HTML][HTML] MicroRNA miR-23a cluster promotes osteocyte differentiation by regulating TGF-β signalling in osteoblasts

HC Zeng, Y Bae, BC Dawson, Y Chen, T Bertin… - Nature …, 2017 - nature.com
Osteocytes are the terminally differentiated cell type of the osteoblastic lineage and have
important functions in skeletal homeostasis. Although the transcriptional regulation of …

Trabecular bone score as a more sensitive tool to evaluate bone involvement in MEN1-related primary hyperparathyroidism

A Song, R Chen, W Guan, W Yu, Y Yang… - The Journal of …, 2024 - academic.oup.com
Context The skeletal involvement of multiple endocrine neoplasia type 1-related primary
hyperparathyroidism (MHPT) is not exactly the same as that of sporadic primary …

Update on multiple endocrine neoplasia Type 1 and 2

A Al-Salameh, C Baudry, R Cohen - La Presse Médicale, 2018 - Elsevier
Key points Multiple endocrine neoplasia type 1 is a rare genetic syndrome, characterized by
the co-occurrence, in the same individual or in related individuals of the same family, of …

[HTML][HTML] Loss of menin in osteoblast lineage affects osteocyte–osteoclast crosstalk causing osteoporosis

P Liu, S Lee, J Knoll, A Rauch, S Ostermay… - Cell Death & …, 2017 - nature.com
During osteoporosis bone formation by osteoblasts is reduced and/or bone resorption by
osteoclasts is enhanced. Currently, only a few factors have been identified in the regulation …

Multiple endocrine neoplasia: genetics and clinical management

JA Norton, G Krampitz… - Surgical Oncology Clinics, 2015 - surgonc.theclinics.com
Multiple endocrine neoplasia type 1 (MEN1) is inherited as an autosomal dominant disorder.
1, 2 It has a prevalence of 2 to 3 per 100,000 3 and is reported to be present in 0.22% to …

[HTML][HTML] Androgen deprivation therapy complications

CA Allan, VR Collins, M Frydenberg… - Endocrine-related …, 2014 - erc.bioscientifica.com
The identification of the multiple endocrine neoplasia type 1 (MEN1) gene in 1997 has
shown that germline heterozygous mutations in the MEN1 gene located on chromosome …

Zoledronic acid enhanced the antitumor effect of cisplatin on orthotopic osteosarcoma by ROS‐PI3K/AKT signaling and attenuated osteolysis

L Liu, H Geng, C Mei, L Chen - Oxidative Medicine and Cellular …, 2021 - Wiley Online Library
Osteoclasts can interact with osteosarcoma to promote the growth of osteosarcoma.
Cisplatin is common in adjuvant chemotherapy of osteosarcoma. However, due to …

[HTML][HTML] A RUNX2-mediated epigenetic regulation of the survival of p53 defective cancer cells

MH Shin, Y He, E Marrogi, S Piperdi, L Ren… - PLoS …, 2016 - journals.plos.org
The inactivation of p53 creates a major challenge for inducing apoptosis in cancer cells. An
attractive strategy is to identify and subsequently target the survival signals in p53 defective …